BioPharma & Healthcare Related News

Gilead Sciences and Kite to Acquire Cell Design Labs

-- Adds Two Technology Platforms that May be Broadly Applicable in Cellular Therapy -- -- Enables Research and Development of Potential Future Generations of CAR T and TCR T-cell Therapies for Solid Tumors -- December 07, 2017 05:00 PM [...]

By | December 8th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders

Partnership Integrates Living Medicine Drug Discovery and Development Expertise with Leading Industrial-Scale Organism Engineering Applied to Therapeutics for the First Time Companies Aim to Expand Portfolio of Novel, Probiotic-Based, Living Medicines with Additional Partners December 08, 2017 06:00 AM Eastern Standard [...]

By | December 8th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products

Financing led by GV to focus on lead programs for next-generation oncology cell therapies Proprietary platform enables installation of pharmacologic operating systems in cell and gene therapy products to provide treating physicians with precise and dynamic control of engineered cells [...]

By | December 7th, 2017|BioPharma & Healthcare, News, Therapeutics|

Editas Medicine, Inc., Announces Pricing of $50 Million Offering of Common Stock

CAMBRIDGE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc.(NASDAQ:EDIT), a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock. The gross proceeds to Editas Medicine from this offering are expected to be [...]

By | December 6th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Lumen Raises $13M for New Biotech Production Platform

Seattle biotech veterans launch a groundbreaking biotech product development platform SEATTLE--(BUSINESS WIRE)--Lumen Bioscience, a synthetic biotechnology company developing a novel bio-based product development platform, announced today it has raised $13 million of new capital, including a Series A investment round [...]

Precision CRISPR Engineering Startup Guide BioSci Named Runner-Up in IDT Synthetic Biology Grant Contest

Guide Biosci has been named runner-up in IDT’s new Synthetic Biology Grant Program and will be receiving 50,000 base pairs of DNA from IDT’s synthetic biology product line, a value of approximately $7,500. The contest was founded this year with [...]

By | November 30th, 2017|BioPharma & Healthcare, Industry Support, News, Therapeutics|